Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Biotech Analysis: List Of Biotech Companies Seeing High Volume Gains (Dec-18)

|Includes:ARIA, ARNA, BSTC, CBM, CBP, CCXI, CXM, DNDN, EBS, Ford Motor Company (F), HPTX, NLNK, SGEN, TEVA, TROV, VNDA, XOMA

Screen Criteria:

List of Biotech stocks, trading higher on larger-than-normal volumes during the most recent trading session. (Link to original post)

Ranking of This List:

This list is currently ranked 132 out of 284 lists tracked by Contextuall.com, i.e. the company characteristics described below have outperformed 53.52% of lists in Contextuall's coverage universe.

Average Weekly Returns:

Average 1-Week Return of All Stocks Mentioned Below: 9.67%

Average 1-Month Return of All Stocks Mentioned Below: 10.96%

Analysis of List Alpha:

Number of Stocks in This List Generating Excess Return vs. SP500 (Beta Adjusted Over Last Week): 13 out of 18 (72.22%)

Number of Stocks in This List Generating Excess Return vs. SP500 (Beta Adjusted Over Last Month): 8 out of 18 (44.44%)

(List sorted by monthly performance, from best to worst)

1. Oncolytics Biotech Inc. (ONCY): Focuses on the development of oncolytic viruses as potential cancer therapeutics. Today's trading volume is 2.84 times larger than normal, with the stock gaining 0.58% during the most recent session.

2. TrovaGene (NASDAQ:TROV): Today's trading volume is 1.54 times larger than normal, with the stock gaining 2.82% during the most recent session.

3. Dendreon Corp. (NASDAQ:DNDN): Engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. Today's trading volume is 2.2 times larger than normal, with the stock gaining 5.69% during the most recent session.

4. Cambrex Corporation. (NYSE:CBM): Provides products and services for the development and commercialization of new and generic therapeutics. Today's trading volume is 2.81 times larger than normal, with the stock gaining 3.23% during the most recent session.

5. BioSpecifics Technologies Corp. (NASDAQ:BSTC): Involves in the development of an injectable collagenase for various indications. Today's trading volume is 1.85 times larger than normal, with the stock gaining 3.86% during the most recent session.

6. NewLink Genetics Corporation (NASDAQ:NLNK): Today's trading volume is 1.61 times larger than normal, with the stock gaining 2.05% during the most recent session.

7. Arena Pharmaceuticals (NASDAQ:ARNA): Focuses on discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. Today's trading volume is 1.5 times larger than normal, with the stock gaining 2.38% during the most recent session.

8. NuPathe (PATH): Focuses on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. Today's trading volume is 5.79 times larger than normal, with the stock gaining 9.49% during the most recent session.

9. Vanda Pharmaceuticals (NASDAQ:VNDA): Focuses on the development and commercialization of products for the treatment of central nervous system disorders. Today's trading volume is 27.41 times larger than normal, with the stock gaining 18.94% during the most recent session.

10. China Botanic Pharmaceutical Inc. (NYSEMKT:CBP): Today's trading volume is 5.09 times larger than normal, with the stock gaining 14.0% during the most recent session.

11. XOMA Corporation (NASDAQ:XOMA): Engages in the discovery, development, and manufacture of therapeutic antibodies to treat inflammatory, autoimmune, infectious, and oncological diseases. Today's trading volume is 1.7 times larger than normal, with the stock gaining 0.75% during the most recent session.

12. ChemoCentryx (NASDAQ:CCXI): Today's trading volume is 2.15 times larger than normal, with the stock gaining 1.08% during the most recent session.

13. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA): Focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. Today's trading volume is 1.87 times larger than normal, with the stock gaining 0.75% during the most recent session.

14. Seattle Genetics Inc. (NASDAQ:SGEN): Focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. Today's trading volume is 1.52 times larger than normal, with the stock gaining 0.09% during the most recent session.

15. Cardium Therapeutics Inc. (NYSEMKT:CXM): Today's trading volume is 2.1 times larger than normal, with the stock gaining 2.11% during the most recent session.

16. Hyperion Therapeutics (NASDAQ:HPTX): Today's trading volume is 5.26 times larger than normal, with the stock gaining 5.0% during the most recent session.

17. Emergent BioSolutions (NYSE:EBS): Develops, manufactures, and commercializes immunobiotics such as vaccines and immune globulins that assist the body's immune system. Today's trading volume is 1.54 times larger than normal, with the stock gaining 0.80% during the most recent session.

18. Oxygen Biotherapeutics (OXBT): Develops medical and cosmetic products that deliver oxygen to tissues in the body. Today's trading volume is 1.81 times larger than normal, with the stock gaining 2.51% during the most recent session.